Apyx Medical Corp Director Lawrence Waldman Exercises Stock Options and Reports Holdings

Lawrence Waldman, a director of Apyx Medical Corp, filed a Form 4 reporting a net exercise of 12,000 stock options on June 30, 2026. The options had an exercise price of $1.88 per share. As part of the exercise, 5,024 shares were withheld by the company at $4.49 per share to cover the exercise price, resulting in the issuance of 6,976 net shares to Waldman. Following the transaction, Waldman holds 37,563 shares directly and additional shares indirectly through a Spousal Lifetime Access Trust (SLAT). The SLAT holdings are reported with a disclaimer of beneficial ownership, except to the extent of any pecuniary interest. The options were set to expire on July 28, 2026, and were exercised through a cashless net exercise arrangement.